(Q37684328)

22 August 2017

Characteristics of Macular Edema in Behcet Disease after Intravitreal Bevacizumab Injection (English)

1 reference

22 August 2017

0 references

1 reference

Fariba Ghassemi

1

0 references

Siamak Sabour

object named as

Siamak Sabour

4

0 references

author name string

Sohrab Afshari Mirak

2

1 reference

22 August 2017

Hormoz Chams

3

1 reference

22 August 2017

Mehdi Nilli Ahmadabadi

5

1 reference

22 August 2017

Fereidoun Davatchi

6

1 reference

22 August 2017

Farhad Shahram

7

1 reference

22 August 2017

1 January 2017

1 reference

Journal of Ophthalmic & Vision Research

22 August 2017

1 reference

22 August 2017

12

1 reference

22 August 2017

1

1 reference

22 August 2017

44-52

1 reference

Update on the therapy of Behçet disease

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Correlation between Ocular Manifestations and Their Complications as Opposed to Visual Acuity and Treatment in Behcet's Disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Macular involvement in patients with Behçet's uveitis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Current trends in the management of ocular symptoms in Adamantiades-Behçet's disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Therapeutic monoclonal antibodies in ophthalmology

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Ocular features of Behcet's disease: an international collaborative study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Bevacizumab for neovascular ocular diseases

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

The pathogenesis and clinical presentation of macular edema in inflammatory diseases

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Mechanisms of fluid accumulation in retinal edema

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Behçet's disease. Report of 41 cases and a review of the literature

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Intravitreal bevacizumab (Avastin) for the treatment of cystoid macular edema in Behçet disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Intravitreal bevacizumab versus triamcinolone acetonide for refractory uveitic cystoid macular edema: a randomized pilot study

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Inflammatory mediators and posterior segment involvement in ocular Behcet disease.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Cytokine profile in Behçet uveitis.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

What does it take to diagnose Behçet disease?

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Behçet's disease: evaluation of a new instrument to measure clinical activity.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5340063

Fluorescein angiographic findings in cases with intermediate uveitis in the inactive phase

1 September 2018

1 reference

12 December 2020

Intravitreal bevacizumab for treatment of uveitic macular edema

1 reference

12 December 2020

Impact of macular edema on visual acuity in uveitis

1 reference

12 December 2020

The role of heat shock protein 60, vascular endothelial growth factor and antiphospholipid antibodies in Behçet disease

1 reference

12 December 2020

Vascular involvement in Behçet's disease: 8-year audit

1 reference

12 December 2020

Enhanced optical coherence patterns of diabetic macular oedema and their correlation with the pathophysiology

1 reference

12 December 2020

Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema

1 reference

12 December 2020

Distinct cytokine and chemokine profiles in the aqueous of patients with uveitis and cystoid macular edema

1 reference

12 December 2020

Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease

1 reference

12 December 2020

Comparison of existing disease activity indices in the follow-up of patients with Behçet's disease

1 reference

12 December 2020

Fundus changes associated with Behçet's disease

1 reference

12 December 2020

Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema

1 reference

12 December 2020

Clinical manifestations of Behçet's disease: an analysis of 2147 patients

1 reference

12 December 2020

Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis

1 reference

12 December 2020

Identifiers

DOI

10.4103/JOVR.JOVR_254_15

1 reference

22 August 2017

1 reference

22 August 2017

1 reference